X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (353) 353
Publication (38) 38
Book / eBook (14) 14
Patent (7) 7
Book Review (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (121) 121
male (79) 79
hematology (77) 77
middle aged (77) 77
female (76) 76
index medicus (74) 74
aged (71) 71
oncology (64) 64
adult (60) 60
rituximab (53) 53
treatment outcome (47) 47
aged, 80 and over (46) 46
leukemia, lymphocytic, chronic, b-cell - drug therapy (41) 41
therapy (33) 33
lymphoma (31) 31
cyclophosphamide (30) 30
fludarabine (29) 29
chronic lymphocytic leukemia (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
cancer (27) 27
antineoplastic agents - therapeutic use (26) 26
lymphomas (26) 26
survival (26) 26
chemotherapy (25) 25
leukemia (22) 22
non-hodgkins-lymphoma (22) 22
prognosis (22) 22
disease-free survival (21) 21
hematology, oncology and palliative medicine (21) 21
recurrence (21) 21
abridged index medicus (20) 20
care and treatment (20) 20
expression (20) 20
leukemia, lymphocytic, chronic, b-cell - pathology (18) 18
patients (18) 18
trial (18) 18
antibodies, monoclonal - therapeutic use (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
apoptosis (17) 17
chronic lymphocytic-leukemia (16) 16
dose-response relationship, drug (16) 16
antineoplastic agents - administration & dosage (15) 15
antineoplastic agents - adverse effects (15) 15
follicular lymphoma (15) 15
analysis (14) 14
antibodies, monoclonal - administration & dosage (14) 14
clinical trials and observations (14) 14
cyclophosphamide - administration & dosage (14) 14
drug administration schedule (14) 14
open-label (14) 14
hemic and lymphatic diseases (13) 13
transplantation (13) 13
article (12) 12
chlorambucil (12) 12
leukemia, lymphocytic, chronic, b-cell - genetics (12) 12
lymphoma, non-hodgkin - drug therapy (12) 12
lymphoma, non-hodgkin - therapy (12) 12
neutropenia (12) 12
research (12) 12
vidarabine - analogs & derivatives (12) 12
antibodies, monoclonal, murine-derived (11) 11
antineoplastic agents - pharmacology (11) 11
cll (11) 11
combination (11) 11
combined modality therapy (10) 10
inhibitor (10) 10
leukemia, lymphocytic, chronic, b-cell - mortality (10) 10
neoplasm staging (10) 10
protein kinase inhibitors - therapeutic use (10) 10
remission induction (10) 10
anti-cd20 monoclonal-antibody (9) 9
antibodies, monoclonal - adverse effects (9) 9
cyclophosphamide - adverse effects (9) 9
diagnosis (9) 9
follow-up studies (9) 9
leukemia, lymphocytic, chronic, b-cell - metabolism (9) 9
lymphocytes b (9) 9
medicine & public health (9) 9
mutation (9) 9
radioimmunotherapy (9) 9
antibodies, monoclonal, murine-derived - administration & dosage (8) 8
antimitotic agents (8) 8
antineoplastic agents (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
b-cell lymphoma (8) 8
bendamustine (8) 8
chronic lymphatic leukemia (8) 8
follow-up (8) 8
hematopoietic stem cell transplantation (8) 8
ibrutinib (8) 8
immune system diseases (8) 8
immunology (8) 8
leukemia, lymphocytic, chronic, b-cell - therapy (8) 8
non-hodgkin-lymphoma (8) 8
pi3k (8) 8
stem-cell transplantation (8) 8
survival rate (8) 8
transplantation, autologous (8) 8
b-cell (7) 7
chemoimmunotherapy (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UTL at Downsview - May be requested (5) 5
Gerstein Science - Stacks (3) 3
OISE - Stacks (2) 2
Physics - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Aerospace - Stacks (1) 1
Astronomy & Astrophysics - Ask at library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Knox College (Caven) - Stacks (1) 1
Mathematical Sciences - May be requested in 6-10 wks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 07/2018, Volume 132, Issue 3, pp. 240 - 241
In this issue of Blood, Phillips et al demonstrate an exciting approach to improve efficacy and decrease the toxicity of phosphatidylinositol 3-kinase (PI3K)... 
HEMATOLOGY
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. 1035 - e623
Lessons Learned The combination of ofatumumab and bendamustine in elderly patients with diffuse large B‐cell lymphoma demonstrated modest efficacy compared... 
TRIAL | MULTICENTER | MONOTHERAPY | ONCOLOGY | RITUXIMAB | OLDER | COMBINATION | Clinical Trial Results
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1856 - 1856
Abstract Introduction In CLL, the timing and selection of therapy is largely informed by disease stage, prognostic molecular features, tumor load, and patient... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3146 - 3146
Abstract Background: Duvelisib (DUV) is a first-in class, oral dual inhibitor of PI3K-δ,-γ being developed for the treatment of advanced B- and T-cell... 
Journal Article
American journal of hematology, ISSN 0361-8609, 09/2019
Duvelisib, a potent δ- and γ-PI3K inhibitor, is a potential therapeutic for hematologic malignancies. Rituximab and bendamustine have demonstrated activity in... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4144 - 4144
Abstract Background: MCL is a subtype of NHL that remains largely incurable with conventional therapies; BR is standard first-line therapy. Acalabrutinib is a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4167 - 4167
Abstract Introduction: Indolent NHL (iNHL) remains largely incurable, with the majority of patients (pts) eventually becoming refractory to standard therapies,... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3136 - 3136
Abstract Background: Aberrant activation of B-cell receptor (BCR) signaling is considered to be a major oncogenic mechanism that leads to the development and... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3063 - 3063
Abstract Background: Ponatinib, an oral tyrosine kinase inhibitor with potent activity against native and mutant BCR-ABL1, is approved for patients with... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Suppl_1, pp. 691 - 691
Abstract Background : Ibrutinib (ibr), a first-in-class, once-daily inhibitor of Bruton's tyrosine kinase, is approved in the US and EU for patients (pts) with... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1602 - 1602
Abstract Introduction:The prognosis is poor for patients with follicular lymphoma (FL) who experience early relapse within 2 years of initial diagnosis and for... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2921 - 2921
Abstract Background: The pivotal phase 3 ECHELON-1 study demonstrated superior efficacy of brentuximab vedotin plus doxorubicin, vinblastine and dacarbazine... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 445 - 445
Abstract Background: Indolent non-Hodgkin lymphoma (iNHL), including follicular lymphoma (FL) and marginal zone lymphoma (MZL), is typically responsive to... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2966 - 2966
Abstract Background: Recent regulatory approvals of two CD19-targeted chimeric antigen receptor (CAR)-expressing autologous T lymphocyte therapies provide... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2566 - 2566
Abstract Background: Malignant cells alter metabolism in order to enable their highly anabolic state. In addition to a massive increase in glycolysis,... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.